{"id":"NCT01780987","sponsor":"Pfizer","briefTitle":"AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients","officialTitle":"Active-control, Multicenter, Randomized, Open-label, Safety And Efficacy Study Evaluating The Use Of Apixaban In The Treatment Of Symptomatic Deep Vein Thrombosis And Pulmonary Embolism In Japanese","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-01","primaryCompletion":"2014-09","completion":"2014-09","firstPosted":"2013-01-31","resultsPosted":"2016-06-23","lastUpdate":"2016-06-23"},"enrollment":80,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Deep Vein Thrombosis","Pulmonary Embolism"],"interventions":[{"type":"DRUG","name":"Apixaban","otherNames":[]},{"type":"DRUG","name":"Unfractionated Heparin (UFH)","otherNames":[]},{"type":"DRUG","name":"Warfarin","otherNames":[]}],"arms":[{"label":"Apixaban","type":"EXPERIMENTAL"},{"label":"UFH/Warfarin","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to investigate safety of apixaban in Japanese acute DVT/PE subjects when symptomatic DVT/PE subjects are treated with 10 mg BID apixaban for 7 days as initial therapy followed by 5 mg BID apixaban for 23 weeks as long-term therapy (total treatment period is 24 weeks)","primaryOutcome":{"measure":"Number of Participants With Major Bleeding Events ［Per International Society on Thrombosis and Homeostasis (ISTH) Definition］ or Clinically Relevant Non-major (CRNM) Bleeding Events Adjudicated by Clinical Event Committee During the Treatment Period","timeFrame":"Baseline to Week 24","effectByArm":[{"arm":"Apixaban","deltaMin":3,"sd":null},{"arm":"Unfractionated Heparin (UFH)/Warfarin","deltaMin":11,"sd":null}],"pValues":[]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":3},"locations":{"siteCount":20,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=B0661024&StudyName=AStudy%20To%20Evaluate%20Safety%20And%20Eficacy%20Of%20Apixaban%20In%20Japanese%20Acute%20Deep%20Vein%20Thrombosis%20%28DVT%29%20And%20Pulmonary%20Embolism%20%28PE%29%20Patie"]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":40},"commonTop":["Constipation","Pyrexia","Nasopharyngitis","Fall","Insomnia"]}}